NFKB1 and mastitis: In vitro studies have shown that sulforaphane downregulates the mRNA expression of inflammatory cytokines, inhibits the expression of inflammatory mediators such as COX-2 and inducible nitric oxide synthase, and suppresses NF-κB activation, thereby alleviating LPS-induced mastitis (49).